Related Experiment Video
Updated: Jul 17, 2025

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Nucleic acid-based therapeutics for the treatment of central nervous system disorders
Robyn McCartan1,2, Olga Khorkova1,3, Claude-Henry Volmar1,2
1Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, Florida, United States.
Abstract:
Nucleic acid-based therapeutics (NBTs) are an emerging class of drugs with potential for the treatment of a wide range of central nervous system conditions. To date, pertaining to CNS indications, there are two commercially available NBTs and a large number of ongoing clinical trials. However, these NBTs are applied directly to the brain due to very low blood brain barrier permeability. In this review, we outline recent advances in chemical modifications of NBTs and NBT delivery techniques intended to promote brain exposure, efficacy, and possible future systemic application.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Microorganisms in Medicine and Therapeutics
Drugs Affecting Neurotransmitter Synthesis
Alzheimer's Disease: Treatment
Neurochemical Transmission: Sites of Drug Action

